Teclison

Developer immunotherapies for the treatment of cancer

placeMontclair, New Jersey, United States calendar_todayFounded 2013 groups6 employees language teclison.com

Innovation

5 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 199 times.

YearFilings
20172
20182
20192
20201
20221
20232
20241
20253
20262

Investor mix

2 investors on record; lead investors include WTT investment.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon